TP53 and cancer: A study of AURKA and regulation of the cell cycle in cancer through multiple signal pathways found that AURKA diminished pRb, p53, P21waf1/cip1, and p27cip/kip but increased Plk1, CDC25, CDK1, and cyclin B1 to promote cell cycle progression [35].